Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients-Reference-Cited by-同舟云学术

Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients

Published:2013-02-05 Issue:6 Volume:27 Page:1391-1393
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Roeker L E,Larson D R,Kyle R A,Kumar S,Dispenzieri A,Rajkumar S V

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201334.pdf

Reference16 articles.

1. Kyle RA, Pierre RV, Bayrd ED . Multiple myeloma and acute myelomonocytic leukemia. N Engl J Med 1970; 283: 1121–1125.

2. Cuzick J, Erskine S, Edelman D, Galton DA . A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults. Br J Cancer 1987; 55: 523–529.

3. Bergsagel DE, Bailey AJ, Langley GR, MacDonald RN, White DF, Miller AB . The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. N Engl J Med 1979; 301: 743–748.

4. Govindarajan R, Jagannath S, Flick JT, Vesole DH, Sawyer J, Barlogie B et al. Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 1996; 95: 349–353.

5. Yang J, Terebelo HR, Zonder JA . Secondary primary malignancies in multiple myeloma: an old nemesis revisited. Adv Hematol 2012; 2012: 801495.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent myelodysplastic malignancies and plasma cell neoplasms; a clinicopathological study with prognostic implications;Leukemia & Lymphoma;2024-08-23

2. Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes;Haematologica;2023-10-19

3. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies;Modern Pathology;2023-06

4. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review;Clinical Lymphoma Myeloma and Leukemia;2023-05

5. Diagnostic relevance of 2‐[ ¹⁸ F]‐FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significance;Hematological Oncology;2022-10-17